Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies
Clinical trial NCT01998035 · TERMINATED
Trial details
- NCT number
- NCT01998035
- Sponsor
- Columbia University
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2020-01-06
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.